BSLN
Basilea Pharmaceutica Ltd. is a Basel-area biopharmaceutical company focused on developing and commercializing innovative anti-infective medicines to address severe bacterial and fungal infections. The company emphasizes research and global commercialization of therapies in areas such as antifungal and antibacterial treatments. Based in Allschwil near Basel, Switzerland, Basilea is listed on the SIX Swiss Exchange and collaborates on partnerships and investor activities to advance its portfolio and pipeline for patients worldwide.
No recent news for this company.